DISPOSITION AND METABOLIC-FATE OF 4- (3-[3-[2-(1-HYDROXYCYCLOHEXYL)ETHYL]-4-OXO-2-THIAZOLIDINYL]PROPYL) BENZOIC ACID-C-14 (I-C-14), A NEW RENAL VASODILATOR

被引:0
|
作者
LEE, LL [1 ]
ZACCHEI, AG [1 ]
COCHRAN, DW [1 ]
机构
[1] MERCK SHARP & DOHME RES LABS,W POINT,PA 19486
来源
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:152 / BIOL
相关论文
共 50 条
  • [21] Synthesis of 14C-labeled 4-hydroxyindole as an intermediate for the preparation of (S)-2-[4-[2-[3-(indol-2-[14C]-4-yloxy)-2-hydroxypropylamino]-2-methylpropyl]- phenoxy]pyridine-5-carboxamide (LY368842-[indole-14C]) glycolate
    Czeskis, BA
    Clodfelter, DK
    Wheeler, WJ
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2002, 45 (13): : 1143 - 1152
  • [22] Synthesis of 1-(1-benzyl-2-ethylthio-2-14C-5-imidazolyl)-4-{3-(1-isopropylamino)-2-pridyl} piperazine
    Saemian, Nader
    Shirvani, Gholamhossein
    Matloubi, Hojatollah
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2007, 50 (5-6): : 576 - 577
  • [23] 3-[2-[4-(4-FLUOROBENZOYL)-1-PIPERIDINYL]ETHYL]-2,4(1H,3H)-QUINAZOLINEDIONE (KETANSERIN), C22H22FN3O3
    PEETERS, OM
    BLATON, NM
    DERANTER, CJ
    CRYSTAL STRUCTURE COMMUNICATIONS, 1982, 11 (01): : 375 - 379
  • [24] Synthesis of (S)-1-(1H-indol-4-yloxy)-3-[4-(3-methoxyphenyl)-4-hydroxypiperidin-1-yl]-propan-2-ol (LY333068) succinate, and its 3-[14C]-isotopomer based on chiral glycerol-[14C] derivatives
    Czeskis, BA
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1998, 41 (06): : 465 - 475
  • [25] Crystal structure of 4-(3-(pyridin-3-yl)ureido) benzoic acid adipic acid (2/1), C16H16N3O5
    Wu, Chong
    Wu, Shou-Ting
    Zhang, Qi-Long
    Zou, Juan
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2020, 235 (05): : 1135 - 1136
  • [26] 3-(1,2-DIPHENYLETHYL)-1,4,5,6-TETRAHYDRO-1,2,4-TRIAZINE-3-C-14 MONOHYDROCHLORIDE
    MCKENDRY, LH
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1980, 17 (01): : 43 - 51
  • [27] Synthesis of Ethyl 2-((E)-3-(E) benzylideneamino)-4-(2-(4'-substituted phenyl)hydrazono)-5-oxo-4,5-dihydro-111-pyrazol-1-y1)Acetate Derivatives
    Nagaraju, G.
    Kumar, Kishore K.
    Spoorthy, Y. N.
    Jayaveera, K. N.
    Ravindranath, L. K.
    CHEMISTRY AND CHEMICAL PROCESS, 2011, : 80 - 85
  • [28] Ethyl 2-[4-(morpholin-4-yl) phenyl]-1-[3-(2-oxopyrrolidin-1-yl)propyl]-1H-1,3-benzimidazole-5-carboxylate monohydrate
    Yoon, Yeong Keng
    Ali, Mohamed Ashraf
    Choon, Tan Soo
    Arshad, Suhana
    Razak, Ibrahim Abdul
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O2967 - +
  • [29] 2-, 3-, and 4-(1-Oxo-1H-2,3-dihydroisoindol-2-yl)benzoic acids and their corresponding organotin carboxylates: Synthesis, characterization, fluorescent, and biological activities
    Cai, Shuang-Lian
    Chen, Yong
    Sun, Wen-Xia
    Li, Hui
    Chen, Yun
    Yuan, Shi-Shan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (19) : 5649 - 5652
  • [30] STRUCTURE OF 3-(2-PYRIDYL)-2-(2-TOLYL)-1,3-THIAZOLIDIN-4-ONE, C15H14N2OS
    HICKEL, D
    LEGER, JM
    CARPY, A
    VIGORITA, MG
    CHIMIRRI, A
    GRASSO, S
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1983, 39 (FEB) : 240 - 245